VEA
RNAM

Virtus ETF Advisers’s Avidity Biosciences RNAM Stock Holding History

Virtus ETF Advisers’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,106
Closed -$61.2K – 722
2024
Q4 		$61.2K Sell
2,106
-199
-9% -$8.32K 0.03% 444
2024
Q3 		$106K Buy
2,305
+40
+2% +$1.74K 0.05% 370
2024
Q2 		$92.5K Sell
2,265
-8,524
-79% -$245K 0.05% 348
2024
Q1 		$275K Sell
10,789
-740
-6% -$11.6K 0.15% 230
2023
Q4 		$104K Buy
11,529
+3,416
+42% +$22.8K 0.07% 341
2023
Q3 		$51.8K Sell
8,113
-807
-9% -$6.95K 0.03% 413
2023
Q2 		$98.9K Buy
8,920
+2,989
+50% +$37.5K 0.06% 387
2023
Q1 		$91K Sell
5,931
-2,284
-28% -$50.3K 0.05% 360
2022
Q4 		$182K Sell
8,215
-637
-7% -$9.5K 0.1% 320
2022
Q3 		$145K Buy
8,852
+71
+0.8% +$1.36K 0.06% 358
2022
Q2 		$128K Buy
8,781
+2,495
+40% +$37.1K 0.05% 359
2022
Q1 		$116K Sell
6,286
-378
-6% -$6.42K 0.05% 276
2021
Q4 		$158K Sell
6,664
-1,525
-19% -$36.4K 0.06% 331
2021
Q3 		$202K Sell
8,189
-424
-5% -$9.22K 0.09% 268
2021
Q2 		$213K Sell
8,613
-525
-6% -$12.2K 0.09% 300
2021
Q1 		$199K Buy
9,138
+166
+2% +$4.06K 0.08% 330
2020
Q4 		$229K Buy
+8,972
New +$262K 0.1% 330

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus ETF Advisers's RNAM Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Avidity Biosciences (RNAM) in Q1 2025, closing a stake of 2,106 shares — an estimated $61.2K sold.

Virtus ETF Advisers first reported a position in RNAM in Q4 2020 and held it in 17 quarters. The position peaked at $275K in Q1 2024. 220 funds tracked by Wall St. Rank hold RNAM as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Avidity Biosciences position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 2,106 Avidity Biosciences shares in Q1 2025, an estimated $61.2K.
  • Virtus ETF Advisers first reported a position in Avidity Biosciences in Q4 2020 and held it in 17 quarters.
  • Virtus ETF Advisers's Avidity Biosciences position peaked at $275K in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Avidity Biosciences as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.